You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Etanercept normalises left ventricular mass in patients with rheumatoid arthritis
|
|---|---|
| Published in |
Annals of the Rheumatic Diseases, August 2012
|
| DOI | 10.1136/annrheumdis-2012-201489 |
| Pubmed ID | |
| Authors |
Claire Immediato Daïen, Pierre Fesler, Guilhem du Cailar, Vincent Daïen, Thibault Mura, Anne-Marie Dupuy, Jean-Paul Cristol, Jean Ribstein, Bernard Combe, Jacques Morel |
| Abstract |
Cardiovascular mortality is increased in patients with rheumatoid arthritis (RA). RA is associated with an increased left ventricular mass index (LVMI), a strong marker of cardiovascular mortality, and vessel abnormalities. Experimental studies have suggested that tumour necrosis factor α (TNFα) may induce LV hypertrophy. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | 1% |
| France | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 73 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 20% |
| Student > Ph. D. Student | 14 | 18% |
| Other | 8 | 11% |
| Student > Postgraduate | 7 | 9% |
| Student > Master | 5 | 7% |
| Other | 14 | 18% |
| Unknown | 13 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 42 | 55% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 8% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Nursing and Health Professions | 2 | 3% |
| Business, Management and Accounting | 1 | 1% |
| Other | 5 | 7% |
| Unknown | 17 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2013.
All research outputs
#18,339,860
of 22,711,242 outputs
Outputs from Annals of the Rheumatic Diseases
#6,388
of 7,197 outputs
Outputs of similar age
#127,897
of 166,604 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#96
of 108 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,197 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.9. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,604 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.